(2018). MDR1和CYP3A5基因多态性对伊马替尼治疗慢性骨髓性白血病预后的影响. Nan Fang Yi Ke Da Xue Xue Bao.
Chicago Style citaat"MDR1和CYP3A5基因多态性对伊马替尼治疗慢性骨髓性白血病预后的影响." Nan Fang Yi Ke Da Xue Xue Bao 2018.
MLA citatie"MDR1和CYP3A5基因多态性对伊马替尼治疗慢性骨髓性白血病预后的影响." Nan Fang Yi Ke Da Xue Xue Bao 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.